| scholarly article | Q13442814 |
| P50 | author | Suely Lins Galdino | Q106359109 |
| P2093 | author name string | Angela Luzia Branco Pinto Duarte | |
| Ivan da Rocha Pitta | |||
| Maira Galdino da Rocha Pitta | |||
| Laurindo Ferreira da Rocha | |||
| Andrea Tavares Dantas | |||
| Priscilla Stela Santana de Oliveira | |||
| Henrique Ataide Mariz | |||
| Juliana Cruz da Silva | |||
| P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) | Q31107094 | ||
| Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus | Q33923351 | ||
| Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 | ||
| Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents | Q34556950 | ||
| Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis | Q34648366 | ||
| Th17 and natural Treg cell population dynamics in systemic lupus erythematosus | Q34978528 | ||
| Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. | Q36229199 | ||
| Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells | Q36275163 | ||
| Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus | Q36403653 | ||
| Interleukin-17 and systemic lupus erythematosus: current concepts | Q37552021 | ||
| Interleukin-17-producing T cells in lupus | Q37769076 | ||
| Hydroxychloroquine: from malaria to autoimmunity | Q37827403 | ||
| Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action | Q37859226 | ||
| Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies | Q38013891 | ||
| New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. | Q38026787 | ||
| Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. | Q38594831 | ||
| Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus. | Q39482640 | ||
| Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. | Q41109148 | ||
| Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort | Q41917167 | ||
| Chloroquine decreases cell-surface expression of tumour necrosis factor receptors in human histiocytic U-937 cells | Q41917909 | ||
| Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. | Q41929601 | ||
| Controlled trial with chloroquine diphosphate in systemic lupus erythematosus. | Q41930670 | ||
| Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial | Q41936586 | ||
| The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus | Q41940281 | ||
| A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus | Q41942545 | ||
| Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling | Q41944676 | ||
| Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. | Q43417859 | ||
| Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus | Q73086966 | ||
| IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients | Q73698956 | ||
| Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium | Q77738643 | ||
| Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity | Q84141763 | ||
| The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus | Q84579960 | ||
| P433 | issue | 6 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| rheumatoid arthritis | Q187255 | ||
| lupus erythematosus | Q188297 | ||
| hydroxychloroquine | Q421094 | ||
| P304 | page(s) | 766-771 | |
| P577 | publication date | 2013-06-01 | |
| P1433 | published in | Clinics | Q26841864 |
| P1476 | title | Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients | |
| P478 | volume | 68 |
| Q64056547 | Altered Th17/Treg Ratio in Peripheral Blood of Systemic Lupus Erythematosus but Not Primary Antiphospholipid Syndrome |
| Q38445764 | Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications |
| Q94571389 | An Update on Current Therapeutic Drugs Treating COVID-19 |
| Q93201918 | Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening |
| Q47628090 | Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis |
| Q90939644 | Chloroquine Is Effective for Maintenance of Remission in Autoimmune Hepatitis: Controlled, Double-Blind, Randomized Trial |
| Q97643153 | Chloroquine as a promising adjuvant therapy for type 1 Diabetes Mellitus |
| Q90999599 | Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases |
| Q38503439 | Chloroquine-containing compounds: a patent review (2010 - 2014). |
| Q35768186 | Constitutive STAT3 Phosphorylation in Circulating CD4+ T Lymphocytes Associates with Disease Activity and Treatment Response in Recent-Onset Rheumatoid Arthritis |
| Q54352730 | Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome. |
| Q36989837 | Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjögren's Syndrome: a Double-Blind Randomized Control Study |
| Q89483209 | Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers |
| Q96231744 | Efficacy and safety of chloroquine plus prednisone for the treatment of autoimmune hepatitis in a randomized trial |
| Q43710718 | Evaluation of Th17-related cytokines and IFNγ production from blood mononuclear cells of moderate and severe asthmatic children reveals methylprednisolone does not decrease IL-22 levels |
| Q37133826 | Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines |
| Q38285841 | Hydroxychloroquine in children with interstitial (diffuse parenchymal) lung diseases |
| Q30275641 | Idiopathic subglottic stenosis is associated with activation of the inflammatory IL-17A/IL-23 axis. |
| Q38883883 | Immunomodulators in SLE: Clinical evidence and immunologic actions |
| Q98775698 | Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants |
| Q92625510 | Management strategies and future directions for systemic lupus erythematosus in adults |
| Q98465740 | Mechanisms Underlying Potential Therapeutic Approaches for COVID-19 |
| Q30276624 | Molecular analysis of idiopathic subglottic stenosis for Mycobacterium species. |
| Q89285609 | Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article |
| Q39151076 | Novel drug delivery of dual acting prodrugs of hydroxychloroquine with aryl acetic acid NSAIDs: Design, kinetics and pharmacological study |
| Q28071300 | Oxidative Stress and Treg and Th17 Dysfunction in Systemic Lupus Erythematosus |
| Q52316454 | Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus. |
| Q93157162 | Relationship between Neutrophil-to-Lymphocyte Ratio and Systemic Lupus Erythematosus: A Meta-analysis |
| Q92615849 | Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis |
| Q38181087 | Th17 cells in immunity and autoimmunity. |
| Q92736091 | The role of microbiome in rheumatoid arthritis treatment |
Search more.